Kush Mints (Cannabis flos Canopy Growth): lineage from Bubba Kush and Animal Mints
Kush Mints is listed in the pharmacy registry in two positions, and its lineage leads to Bubba Kush and Animal Mints. We gather what is derived from the documentation about the strain, and separately what has not been demonstrated for it.
| Strain Card | Kush Mints |
|---|---|
| Producers | Canopy Growth (2 pharmacy positions) |
| Medical Brand | same as producer |
| Alternative Names | none |
| Category by sources | hybrid |
| Leading Terpene | limonene |
| Other Terpenes | caryophyllene linalool |
| Lineage | established Bubba Kush × Animal Mints |
| Source Consistency | one source |
- Who supplies. Exclusively Canopy Growth, so there is nothing to compare versions, and a supply break means no strain, not another version of it.
- Profile. Led by limonene, alongside caryophyllene, linalool. We do not provide percentage shares, as sources count them against different totals.
- Origin. Established lineage, parents are Bubba Kush and Animal Mints.
- What is missing. The profile describes one source, so there is nothing to compare it with.
What is Kush Mints and where does this strain come from?
Kush Mints is a hybrid with an established lineage: its parents are Bubba Kush and Animal Mints, and it was bred by Seed Junky Genetics. It reaches Polish pharmacies as hemp flower, which is a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category, currently listed in two separate positions from one producer.
The parental pair comes from two independent genetic catalogs, which consistently list it and indicate the same breeder. This resolves the question of origin and nothing more. The lineage indicates from whom the plant inherited its genes, but does not directly translate to the chemical composition of the batch that reaches the pharmacy shelf: this depends on the growing conditions, as well as when the plant was harvested and how it was dried.
The name component itself proves nothing, and this is particularly evident in this context. The word “kush” carries ten cultivars, half of which have documented parents, and half have none: Afghan Kush, Hindu Kush, Master Kush, OG Kush, and Pink Kush remain without established origins. Kush Mints belongs to the group with lineage not because of how the name sounds, but because the breeder revealed the parental pair, and the catalogs repeated it.
Both profile databases we use for this comparison consistently describe this strain as a hybrid, and none assigns it an advantage on either side of the division into stimulating and calming strains. However, the consistency pertains only to the label itself, as outside of it, one of these databases does not provide any information about the composition.
Which producers supply Kush Mints to Polish pharmacies?
One producer, Canopy Growth, but in two separate pharmacy positions. Some databases label these positions with the medical brand Spectrum Therapeutics, which makes the list appear to be from two different companies at a cursory glance. The positions differ in which terpene is indicated as leading. Current availability is noted in a collective summary of strains.
| Listing in the registry | Terpene indicated in the registry as leading | What the profile databases note about the position |
|---|---|---|
| Canopy Growth, registered name | limonene | the registered name of both described positions leads to this entity |
| Spectrum Therapeutics, medical brand | caryophyllene | the profile database assigns both registered positions to it, marking one as unavailable |
The double entry in the first column is not a flaw in the summary, but a remnant of the naming convention. Spectrum Therapeutics is a medical brand of Canopy Growth, so the same company appears in the databases twice: once under the registered designation, and once under the trade name. The pharmacy registry separates this into individual rows, although the producer stands behind them as one. Anyone looking for “that one” version of Kush Mints will still find two positions, as each has its own declaration and its own entry on availability.
The declared potency of the flower is not provided in this text at all. Sources note only the nominal number for both positions, without the tolerance with which the producer measures it, and without it, a fair range cannot be recorded. A single number would suggest accuracy, which is not present in this data. Prices and current assortment are collected separately in the summary of available strains.
A broader picture of this supplier, meaning what other strains it carries and how its presence in pharmacies looks, is described in the entry about Canopy Growth. The form of the raw material does not change between positions: in both cases, the flower intended for the preparation of a compounded medicine reaches the pharmacy, not goods from the retail category.
What does Kush Mints smell and taste like?
- caryophyllene caryophyllene
- limonene limonene (leading in the pharmacy registry)
- linalool linalool
Minty and herbal, with a pine and earthy note. This is how this strain is described by the profile database we use, and it is the only public sensory description we found for it. Mint is listed first, which corresponds to the second part of the trade name.
The terpene composition is noted by the same single database and lists caryophyllene, limonene, and linalool. This is the entire available description: the second Polish database we check for each strain does have a registry entry for Kush Mints, but does not provide the order or weight of terpenes in it. One source is too little to speak of a confirmed profile, and we treat this composition accordingly here.
We do not record shares as numbers, and this is not about editorial caution. The service provides three equal values for this strain, which do not close the whole, and for other strains, the same fields sum up to something different in each database. The denominator remains unknown, so the number placed next to the terpene name looks like a measurement result, but is the editorial weight of the service.
The smell does not predict the effect. The minty or pine note speaks of volatile components that have survived drying and storage, and these diminish faster than the rest of the raw material: an opened package long ago smells weaker than the same freshly opened one. Inferring from the aroma how the strain will act on a specific person has no basis in data.
How long does it take for Kush Mints to take effect and how long does the effect last?
This depends on the route of administration, not the strain. After vaporization, the first sensations come within a few minutes, and the entire episode closes within a few hours; after ingestion, the onset shifts by hours and the duration extends by the same amount. No one has measured this for Kush Mints itself.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After ingestion | |
|---|---|---|
| First sensations | within a few minutes | from half an hour to two |
| Onset | another dozen to thirty minutes | slow, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | dosing after thirty minutes, which gives both doses at once |
In the pharmacy, Kush Mints is dispensed as flower, and which of the two routes of administration the patient will take depends on how the compounded medicine prescribed on the prescription is prepared. The strain name does not change anything in this calculation: the same time ranges apply to both positions from the registry and to any other position from the same group of raw materials.
What is known and what is not known about the effects of Kush Mints?
Nothing has been demonstrated for the cultivar itself. No clinical study has been published that would test Kush Mints as a strain. Available publications concern individual terpenes administered to animals, and the distance from such a model to a patient in a pharmacy is great, so they do not replace data for the flower.
What is known is what has been demonstrated for limonene, the terpene indicated as leading in one of the pharmacy positions of this strain, and this has been demonstrated on rodents.
| Study | Model and route of administration | What was demonstrated |
|---|---|---|
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Limonene administered intraperitoneally in mice showed muscle relaxant effects (rota-rod test) from a dose of 50 mg/kg and prolonged sleep induced by pentobarbital at a dose of 200 mg/kg (about 2.6 times); in the elevated plus maze test, already at a dose of 5 mg/kg, it reduced the number of entries into the open arms, which the authors described as an anxiogenic effect, not anxiolytic. |
| Fakhri S et al., 2025 Behavioural Pharmacology PMID:40622197 |
rodent (rat and mouse) | Limonene reduced paw swelling induced by carrageenan in rats and pain responses in the formalin test in mice; the effect was linked to the l-arginine/nitric oxide/cGMP/KATP channel pathway and involvement of opioid and benzodiazepine receptors. |
No anxiolytic effects of limonene have been demonstrated in humans. It has also not been shown that isolated limonene has anxiolytic effects in animals; the only available data from the elevated plus maze test showed in mice the opposite effect, reducing the number of entries into the open arms even at a low dose.
Separately from this stands the supplier’s material and patient reports. The profile database labels this strain as having a “balanced” effect, which is an editorial classification of the service, not a measurement result. Similarly, descriptions circulating on forums remain reports that no one has collected in a way that allows anything to be counted.
What side effects have been reported from this strain?
None that could be attributed specifically to this strain. Reports of side effects in Poland are associated with a specific medicinal product and batch number, not with the trade name of the cultivar, so public summaries do not contain a column where Kush Mints could appear.
Reports of side effects are collected for the medicinal product with a batch number, not for the strain name, so the following pertains to hemp flower as a group of raw materials. The most commonly reported are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public summaries for hemp flower in Poland do not separate them by individual products.
The above applies equally to both pharmacy positions of Kush Mints and to any other name from the registry, as it describes the raw material, not the plant. The assessment of whether the flower is even an option for a specific person belongs to the doctor who knows the entire list of preparations they are taking.
How to vaporize Kush Mints?
There is no single setting for this strain. The boiling temperatures of the terpenes in its profile vary widely: limonene boils under atmospheric conditions around 178 degrees Celsius, linalool around 196, and caryophyllene only above 250, so no single setting encompasses them all at once.
These numbers describe the boiling of the pure compound, not the moment when its scent appears in the vapor. Evaporation begins significantly below the boiling temperature and increases gradually, so the limits from the tables are not on/off thresholds. The discrepancies between the tables of temperatures themselves are explained in a separate entry about their comparability.
Caryophyllene is a good example of how easy it is to make a mistake. Internet compilations provide around 130 degrees for it, which sounds convenient as it falls within the working range of vaporizers. However, this value comes from a measurement at a reduced pressure of 14 mmHg, and at atmospheric pressure, the same compound boils above 250 degrees. One number, two completely different conditions, and only the second corresponds to what happens in the vaporizer chamber.
The device setting is not the temperature of the flower: between the heater and the material are airflow and the material itself, so the raw material can be cooler than the number on the display. How terpenes evaporate from the flower is described in a separate entry, and the difference between the setting and the temperature of the material is another.
Which strains are related to Kush Mints?
| Strain | Common Parent | Leading Terpene | Producers |
|---|---|---|---|
| Triangle Mints | Animal Mints | caryophyllene | S-LAB, Synoptis Pharma |
One of the strains available in Polish pharmacies: Triangle Mints. Both strains share a common parent, Animal Mints, and both come from the same breeder. The second parent is different: for Kush Mints it is Bubba Kush, for Triangle Mints it is the Triangle Kush strain, and this is where the differences begin.
The common parent is a specific, named strain, not a broad family style, and that is why this relationship matters. If both positions only shared “kush” or “afghani,” there would be nothing to discuss, as such terms describe a category, not an identified plant. The profile, despite the common parent, turns out differently: for Triangle Mints, caryophyllene is listed as leading, and the database lists five terpenes for it instead of three. Details are collected in a separate entry about this strain.
The “mints” component works exactly the same way as “kush,” meaning it does not work. The registry also lists Frozen Lemon Mints, for which no available source provides parents, and Animintz, derived from Animal Cookies and SinMint Cookies, thus from a completely different pair than Kush Mints. None of them are siblings of this strain, despite the similar-sounding names.
Aside from Triangle Mints, the pedigree chart does not indicate any other siblings of Kush Mints available in Polish pharmacies. The empty remainder of the list is a result, not a gap: adding strains based on similar names creates connections that no one has ever confirmed, and which then travel further through subsequent descriptions.
Frequently Asked Questions about Kush Mints
Does Kush Mints have an established lineage?
Yes. The parents of this strain are Bubba Kush and Animal Mints, and this pair is consistently listed by two independent genetic catalogs, indicating the same breeder.
How many suppliers have this strain in Polish pharmacies?
One: Canopy Growth. The pharmacy registry lists two separate positions for this strain, signed once with the registered name, once with the medical brand Spectrum Therapeutics, and differing in which terpene is indicated as leading.
Does the “kush” component in the name indicate a relationship with other strains?
No. This word carries ten cultivars from this list, and half of them have no established parents at all. Relationship comes from lineage, not from the sound of the name.
Why is there no THC content in this text?
Because sources provide only the nominal number for both positions, without the tolerance with which the producer measures it. Without tolerance, a fair range cannot be recorded, and a single number would suggest accuracy, which is not present in this data.
Is Kush Mints related to Triangle Mints?
Yes. Both strains share a common parent, Animal Mints, and come from the same breeder. The second parent is different, and the leading terpene noted for Triangle Mints is caryophyllene.
Has it been shown that limonene has anxiolytic effects?
No. Such effects have not been demonstrated in humans, and the only available animal data from the elevated plus maze test showed in mice the opposite effect, described by the authors as anxiogenic.
Hemp flower remains a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category. The above text collects publicly available data about one position from the registry and does not replace a conversation with the attending physician or pharmacist.
Author: ubucha.pl editorial team
